ENQUETE-COSYS: French Study on COgnitive Enhancement and Consumption of Psychoactive Substances Among Youth Students
Study Details
Study Description
Brief Summary
This descriptive and declarative study will help to find out consumption rates, all psychoactive substances taken together, among 18-25 year olds. More specifically, it will allow assessment of the extent of the cognitive enhancement phenomenon among students in France (including study of misuse of methylphenidate (MPH) and modafinil in improvement of cognitive performance).
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
This descriptive and declarative study will help to find out consumption rates, among 18-25 year olds, all psychoactive substances (PAS) taken together. More specifically, it will allow assessment of the extent of the cognitive enhancement phenomenon among students in France (including study of misuse of methylphenidate (MPH) and modafinil, two drugs diverted from their indications for improvement of cognitive performance).
Since Faculties of Sciences and Technics of Physical and Sports Activities (UFR STAPS) are involved in the study, the issue of doping in Sports will also be addressed.
The main aim of this national study will be to assess for two successive academic years the proportion and motives of consumption of PAS as part of cognitive enhancement among students in real life.
Secondary aims will be: assessing consumption of PAS and desired effects when such consumption beyond cognitive enhancement (experimental, recreational, abusive or therapeutic use) but also comparing PAS uses in terms of a variety of characteristics (sex, age, field, year of study) and finally to consider more broadly the health of students in a doping behavior (impact of the use of products on health, whether cognitive enhancement is found to be ethically acceptable or not).
The study will be conducted during a period of 3 years, between September 2016 and September 2019, according to a standardized methodology identical in every school involved and a procedure based on an online self-administrated and anonymous survey questionnaire. The questionnaire, elaborated on Limesurvey®, will be available for two successive academic years for all students aged more than 18 years old. It is set up and hosted on a secured high-capacity web server via the website of AP-HP.
The study will also search to assess the level of representation of the sample of respondents regarding the general population of students. Various criteria: the proportion of subjects by field, the proportion of respondents by study year and the sex ratio will be compared to data of general statistics from the Ministry of Research and Higher Education. A representative sample will allow us to assimilate our respondents to the general population of students and estimate the prevalence of PAS consumption among students.
METHODS
For each product, a descriptive analysis of frequency will be done (consumption pattern, consumer's opinion, feeling of dependency, efficacy of the product). For those most frequently used, complementary analysis will be done in order to identify particular profiles.
On the statistical level, univariate analysis will be performed using the Chi-square test and analysis of variance. Then, multivariate analysis will allow us to study independent factors such as age and study year for instance.
The number of respondents expected is approximately 30 000. The sample will also allow us to identify factors associated with PAS consumption (MPH or modafinil particularly) by multivariate modeling using a "split" of the sample procedure with one half used for the construction of the model and the other for its validation.
Study Design
Outcome Measures
Primary Outcome Measures
- Rate of PAS use for the purpose of cognitive enhancement among students since the beginning of the school year, depending on the school [between January and April 2017 and January and April 2018]
Secondary Outcome Measures
- Rate of use for each PAS [between January and April 2017 and January and April 2018]
- Motives of consumption : hedonic (festive, recreational, experimental, boredom management) [between January and April 2017 and January and April 2018]
- Motives of consumption : performance (creativity, sports, cognition) [between January and April 2017 and January and April 2018]
- Motives of consumption : therapeutic (sleep disorder, anxiety, sadness, weight control) [between January and April 2017 and January and April 2018]
- Motives of consumption : social (making friends, being noticed, assertion of identity)control) [between January and April 2017 and January and April 2018]
- Consumption pattern (dose, route of administration, frequency, way to obtain, associated drugs, period) [between January and April 2017 and January and April 2018]
- Comparison PAS uses in terms of a variety of characteristics of subjects (sex, age, sector, year of study). [between January and April 2017 and January and April 2018]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Subjects aged more than 18 years old
-
Students (University, BTS, Grandes Ecoles, IFSI, preparatory classes) registered in the ongoing year
Exclusion Criteria:
- Minor subjects
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | CHU Clermont-Ferrand - service de santé publique | Clermont Ferrand | France | 63000 |
Sponsors and Collaborators
- Assistance Publique - Hôpitaux de Paris
- Mission Interministérielle de Lutte contre les Drogues et les Conduites Addictives - MILDECA
- Agence Nationale de sécurité du Médicament
Investigators
- Principal Investigator: DJEZZAR Samira, Assistance Publique - Hôpitaux de Paris
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- UC1602